242 related articles for article (PubMed ID: 26675313)
21. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
22. Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy.
Sahgal A; Jabbari S; Chen J; Pickett B; Roach M; Weinberg V; Hsu IC; Pouliot J
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):247-54. PubMed ID: 18722275
[TBL] [Abstract][Full Text] [Related]
23. Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning.
Haworth A; Williams S; Reynolds H; Waterhouse D; Duchesne GM; Bucci J; Joseph D; Bydder S; Ebert M
Brachytherapy; 2013; 12(6):628-36. PubMed ID: 23871660
[TBL] [Abstract][Full Text] [Related]
24. A gEUD-based inverse planning technique for HDR prostate brachytherapy: feasibility study.
Giantsoudi D; Baltas D; Karabis A; Mavroidis P; Zamboglou N; Tselis N; Shi C; Papanikolaou N
Med Phys; 2013 Apr; 40(4):041704. PubMed ID: 23556874
[TBL] [Abstract][Full Text] [Related]
25. Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer.
Zaider M; Zelefsky MJ; Cohen GN; Chui CS; Yorke ED; Ben-Porat L; Happersett L
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):702-13. PubMed ID: 15708248
[TBL] [Abstract][Full Text] [Related]
26. Placement of empty catheters for an HDR-emulating LDR prostate brachytherapy technique: comparison to standard intraoperative planning.
Niedermayr TR; Nguyen PL; Murciano-Goroff YR; Kovtun KA; Neubauer Sugar E; Cail DW; O'Farrell DA; Hansen JL; Cormack RA; Buzurovic I; Wolfsberger LT; O'Leary MP; Steele GS; Devlin PM; Orio PF
Brachytherapy; 2014; 13(4):375-9. PubMed ID: 24613569
[TBL] [Abstract][Full Text] [Related]
27. A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients.
Butler WM; Stewart RR; Merrick GS
Med Phys; 2009 Mar; 36(3):776-87. PubMed ID: 19378738
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
29. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
[TBL] [Abstract][Full Text] [Related]
30. Class solution for inversely planned permanent prostate implants to mimic an experienced dosimetrist.
Lessard E; Kwa SL; Pickett B; Roach M; Pouliot J
Med Phys; 2006 Aug; 33(8):2773-82. PubMed ID: 16964853
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative optimized inverse planning for prostate brachytherapy: early experience.
Messing EM; Zhang JB; Rubens DJ; Brasacchio RA; Strang JG; Soni A; Schell MC; Okunieff PG; Yu Y
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):801-8. PubMed ID: 10386636
[TBL] [Abstract][Full Text] [Related]
32. Effect of random seed placement error in permanent transperineal prostate seed implant.
Bues M; Holupka EJ; Meskell P; Kaplan ID
Radiother Oncol; 2006 Apr; 79(1):70-4. PubMed ID: 16515813
[TBL] [Abstract][Full Text] [Related]
33. Development of an adjoint sensitivity field-based treatment-planning technique for the use of newly designed directional LDR sources in brachytherapy.
Chaswal V; Thomadsen BR; Henderson DL
Phys Med Biol; 2012 Feb; 57(4):963-82. PubMed ID: 22297292
[TBL] [Abstract][Full Text] [Related]
34. Calculating prescription doses for new sources by biologically effective dose matching.
Pritz J; Forster KM; Saini AS; Biagioli MC; Zhang GG
Brachytherapy; 2012; 11(6):521-7. PubMed ID: 22436519
[TBL] [Abstract][Full Text] [Related]
35. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.
Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ
Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041
[TBL] [Abstract][Full Text] [Related]
36. Focal prostate brachytherapy with (103)Pd seeds.
Butler WM; Merrick GS
Phys Med; 2016 Mar; 32(3):459-64. PubMed ID: 27053451
[TBL] [Abstract][Full Text] [Related]
37. Introduction of inverse dose optimization for ultrasound-based high-dose-rate boost brachytherapy: how we do it in Kiel.
Siebert FA; Wolf S; Bertermann H; Nürnberg N; Bockelmann G; Kimmig B
Brachytherapy; 2014; 13(3):250-6. PubMed ID: 24613132
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.
Nicolae A; Morton G; Chung H; Loblaw A; Jain S; Mitchell D; Lu L; Helou J; Al-Hanaqta M; Heath E; Ravi A
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):822-829. PubMed ID: 28244419
[TBL] [Abstract][Full Text] [Related]
39. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
40. Effect of planning margin on dosimetric quality in 131Cs permanent prostate brachytherapy.
Li T; Fountain BL; Duffy EW
Brachytherapy; 2010; 9(2):159-64. PubMed ID: 19853535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
